Niagen Bioscience
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $31,117 | $30,481 | $29,125 | $25,580 |
Gross Profit | 20,226 | 19,331 | 18,197 | 16,240 |
EBITDA | 3,540 | 5,140 | 7,469 | 1,968 |
EBIT | 3,185 | 4,772 | 7,111 | 1,602 |
Net Income | 3,609 | 5,063 | 7,179 | 1,878 |
Net Change In Cash | 31,117 | 30,481 | 29,125 | 25,580 |
Free Cash Flow | 1,115 | 7,851 | 8,514 | 3,454 |
Cash | 60,322 | 55,464 | 44,508 | 32,246 |
Basic Shares | 86,241 | 83,232 | 81,681 | 77,768 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $99,597 | $83,570 | $72,050 | $67,449 |
Gross Profit | 61,586 | 50,780 | 42,797 | 41,490 |
EBITDA | 9,210 | -3,894 | -16,744 | -25,447 |
EBIT | 7,726 | -5,599 | -18,628 | -27,073 |
Net Income | 8,550 | -4,938 | -16,540 | -27,128 |
Net Change In Cash | 99,597 | 83,570 | 72,050 | 67,449 |
Free Cash Flow | 11,946 | 6,969 | -15,432 | -24,572 |
Cash | 44,508 | 27,173 | 20,289 | 28,019 |
Basic Shares | 79,724 | 74,985 | 69,729 | 67,185 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.04 |
2025-03-31 | $0.04 |
2024-12-31 | $0.03 |
2024-09-30 | $0.02 |
